Project description
Building modular organ model systems
Biomedical research relies on testing of potential therapies in physiologically relevant systems. With scientists working to minimise animal use, so-called organ-on-chips are gaining ground. These are miniature versions of tissues, organs and even organ systems. Among ongoing experiments are organ-on-chips for bone and cartilage, brain, the gastrointestinal tract, liver, lung, microvasculature, skeletal muscle and skin. Despite their promise, some technical challenges to be overcome with organ-on-chips include throughput and standardisation. PTOoC is planning a step-change in functionality, reliability, and repeatability. During the project, a library of components to produce tissue- and organ-testing systems in a plug-and-play fashion (akin to that for software and electronic devices) will be developed. Standardisation for organ-on-chips could be around the corner.
Objective
Off late, there has been a tremendous surge in the cost of bringing new drugs to the market. The rising costs and ethical concerns related to screening with animal models have led to the development of alternate approaches for drug discovery. Owing to the advantages of high physiological relevance and predictive value, Micro-physiological systems (MPSs) (also referred to as Organ-on-chips (OoC)) are gradually taking over as powerful and cost-effective alternative to animal model-based drug screening. However, OoCs have yet to cross certain key barriers, before they are adopted as an industry standard for drug screening. The current state-of-the-art in OoCs suffer from a low standardization level, low throughput workflow, in comparison to conventional cell culture-based methods. The main objective of the project is to design and develop a library of inter-lockable hard-soft hybrid components, which can be used to construct any given organ-on-chip at the required physiological/functional scale. Each part of the library would serve to enable a certain physicochemical stimulus/structure warranting its use in the design of a specific type of organ-on-chip. The overall library would contain all the required parts to enable implementation of different microenvironments from different organs of the human body. The development of such parts would enable a standardized approach to OoC development and testing across the industry. The project will have a preliminary focus on demonstrating the proof-of-concept for assembling a lung-on-chip OoC from the developed modular components. Followed by integration of different organ-on-chips with functional scaling and parallelization for high-throughput. The project has a strong multi-disciplinary nature with expertise involved from fields of engineering/mechanical design, microfluidics, biological cell culture/microbiology.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- natural sciences physical sciences classical mechanics fluid mechanics microfluidics
- engineering and technology mechanical engineering applied mechanics
- engineering and technology other engineering and technologies microtechnology organ on a chip
- natural sciences biological sciences microbiology
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2018
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
75011 Paris
France
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.